Manage Your Liver
Q:

Why does the current hepatitis B drug treatment have serious deficiencies?

Why does the current hepatitis B drug treatment have serious deficiencies?
A:

The current medication for hepatitis B may be able to stop virus replication, but there are also some major shortcomings, mainly due to the toxicity of the drug itself.1 In addition, the patient is required to use the drug for a long period without stopping. Besides, the medication cannot prevent liver fibrosis and does not contribute to liver health protection.2 So what can chronic hepatitis B patients do to make up for these shortcomings? Is a better or more comprehensive treatment possible?

 

Chronic hepatitis B is a common liver disease where the hepatitis virus continuously replicates in the body, attacking the liver and leading to chronic inflammation. Patients normally have a high level of liver enzymes (ALT & AST). Now, the current main stream treatment is to use medication to control the replication of hepatitis virus, so that the virus count lowers, thereby reducing the attacks and inflammation of the liver. 3

 

It has to be made clear that the only purpose of this medication is to limit and stop viral replication, meaning that it does not and cannot cure the disease. Moreover, the patient is required to take the medication for life, because once it is stopped, the virus will resume its replication. Also, the medication does not promote recovery of liver cells, meaning that the inflammation or damage done remains until the liver is repaired by itself. Most importantly, using the medication does not guarantee that liver function will return to normal as this depends on the liver’s  own recovery ability.

 

Another obvious downside of the drug is that like all other drugs, it contains toxicity. Long-term use will definitely pose adverse effect on human health, especially the liver, since it is the main organ responsible for the decomposition of toxins. 4

 

The disadvantages of using medication to treat chronic hepatitis B are evident; therefore measures to make up for these shortcomings should be incorporated into the treatment program to make it more all-rounded. Patients are recommended to enhance their liver’s self-healing ability and to adopt protective measures to guard liver health. Only by doing these can patients ensure their liver cells are protected from injuries caused by long term medications, not suffer from any side effects of the drugs and prevent liver fibrosis, cirrhosis and other chronic liver diseases

 

Click for more information about enhancing liver’s self-healing ability and protection.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
hepatitis B treatmenthep B medicationhepatitis B drug treatmentliver protection
Related Questions
A:
When we feel sick, a lot of us tend to use whatever medications the doctor prescribes to us, and we are bound to follow their instructions in using these medications, right?   Not quite.   I’ve seen lots of “must have medications” that actually worsen liver function. Or at the very least, lower the quality of life. That’s because…   Medications are like French fries
A:
World Hepatitis Day 2016 is just around the corner (on July 28), aiming to boost global awareness on hepatitis, this year’s campaign is “Elimination” which can be achieved through universal vaccination, enhanced blood and injection safety, as well as harm reduction and treatment [1].   Controlling or eliminating the hepatitis virus has always been regarded as the only way to treat hepatitis. When patients are diagnosed with hepatitis, antiv
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us